Blunted cGMP response to agonists and enhanced glomerular cyclic 3′,5′-nucleotide phosphodiesterase activities in experimental congestive heart failure
- 1 November 1996
- journal article
- Published by Elsevier in Kidney International
- Vol. 50 (5) , 1718-1725
- https://doi.org/10.1038/ki.1996.491
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Inhibition of cyclic GMP phosphodiesterases augments renal responses to atrial natriuretic factor in congestive heart failureJournal of Cardiac Failure, 1994
- Isozymes of cyclic-3′,5′-nucleotide phosphodiesterases in renal epithelial LLC-PK1 cellsKidney International, 1992
- Decreased atrial natriuretic factor receptors and impaired cGMP generation in glomeruli from the cardiomyopathic hamsterBiochemical and Biophysical Research Communications, 1989
- Renal and Adrenal Resistance against Atrial Natriuretic Peptide in Congestive Heart Failure: Effect of Angiotensin I-Converting-Enzyme InhibitionCardiology, 1989
- Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion.Journal of Clinical Investigation, 1986
- Stimulation of cyclic GMP synthesis in human cultured glomerular cells by atrial natriuretic peptideFEBS Letters, 1986
- Concentrating defect in the adrenalectomized rat. Abnormal vasopressin-sensitive cyclic adenosine monophosphate metabolism in the papillary collecting duct.Journal of Clinical Investigation, 1983
- Cellular Action of Vasopressin in Medullary Tubules of Mice with Hereditary Nephrogenic Diabetes InsipidusJournal of Clinical Investigation, 1980
- Modulation of Cyclic Nucleotides in Isolated Rat GlomeruliJournal of Clinical Investigation, 1978
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976